Clinical Trial Update: First Time in Human Study Using GSK2330672 [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of GSK2330672 for type 2 diabetes mellitus has been completed, sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK2330672

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED